New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
10:00 EDTCROX, CNVR, SBMRY, VECO, SNN, ITRI, EXXI, SCOR, ZTS, TRIP, ROLL, SGNT, SGEN, BUD, WCN, TCBK, PESOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Itron (ITRI) upgraded to Buy from Hold at Needham... Pioneer Energy (PES) upgraded to Buy from Speculative Buy at Global Hunter... RBC Bearings (ROLL) upgraded to Buy from Neutral at BofA/Merrill... Smith & Nephew (SNN) upgraded to Buy from Hold at Deutsche Bank... Sprint (S) upgraded to Buy from Hold at Deutsche Bank... TriCo Bancshares (TCBK) upgraded to Strong Buy from Outperform at Raymond James... TripAdvisor (TRIP) upgraded to Outperform from Sector Perform at RBC Capital... Veeco (VECO) upgraded to Outperform from Neutral at Credit Suisse... Waste Connections (WCN) upgraded to Buy from Hold at BB&T... Zoetis (ZTS) upgraded to Outperform from Market Perform at William Blair... SABMiller (SBMRY) upgraded to Conviction Buy from Buy at Goldman... AB InBev (BUD) upgraded to Buy from Sell at Goldman... comScore (SCOR) upgraded at Northland Securities... Conversant (CNVR) upgraded to Buy from Hold at Craig-Hallum... Seattle Genetics (SGEN) upgraded to Buy from Hold at Needham... Energy XXI (EXXI) upgraded to Buy from Accumulate at KLR Group... Crocs (CROX) upgraded to Overweight from Neutral at Piper Jaffray... Sagent Pharmaceuticals (SGNT) upgraded to Outperform at RBC Capital.
News For ITRI;PES;ROLL;SNN;TCBK;TRIP;VECO;WCN;ZTS;SBMRY;BUD;SCOR;CNVR;SGEN;EXXI;CROX;SGNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
February 9, 2016
16:06 EDTSGENSeattle Genetics sees FY16 revenue $390M-$430M, consensus $414.18M
Subscribe for More Information
16:05 EDTSGENSeattle Genetics reports Q4 EPS (18c), consensus (20c)
Subscribe for More Information
08:53 EDTWCNWaste Connection sees FY16 CapEx roughly $230M
Subscribe for More Information
08:52 EDTWCNWaste Connection sees Q1 revenue roughly $515M, consensus $518.09M
Sees Q1 adjusted EBITDA roughly $169M. Sees Q1 depreciation and amortization expense about 13.3% of revenue. Sees Q1 effective tax rate roughly 39.2%. Says asset positioning should allow company to immediately benefit from activity in E&P segment. Says integration planning underway in Canada and U.S., says "very encouraged" by early takeaways. Says outlook assumes no change in economic environment. Comments taken from Q4 earnings conference call.
February 8, 2016
16:15 EDTWCNWaste Connections sees FY16 revenue $2.2B-$2.22B, consensus $2.21B
Subscribe for More Information
16:14 EDTWCNWaste Connections reports Q4 adjusted EPS 49c, consensus 47c
Subscribe for More Information
14:28 EDTWCNNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Twenty-First Century Fox (FOX, FOXA), consensus 44c... Plains All American Pipeline (PAA), consensus 46c... Waste Connections (WCN), consensus 47c... Molina Healthcare (MOH), consensus 61c.
14:01 EDTBUDEarnings Watch: Analysts becoming more positive on Coca-Cola
Subscribe for More Information
February 4, 2016
10:01 EDTSGEN, ZTSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AT&T (T) initiated with a Buy at DA Davidson... Abaxis (ABAX) initiated with an Underperform at Credit Suisse... Aratana Therapeutics (PETX) initiated with an Outperform at Credit Suisse... Care.com (CRCM) initiated with an Equal Weight at Morgan Stanley... GCP Applied Technologies (GCP) initiated with a Buy at Jefferies... Heritage-Crystal Clean (HCCI) initiated with a Buy at Roth Capital... IDEXX (IDXX) initiated with an Outperform at Credit Suisse... Nexvet Biopharma (NVET) initiated with an Outperform at Credit Suisse... PetMed Express (PETS) initiated with an Underperform at Credit Suisse... Phibro Animal Health (PAHC) initiated with an Outperform at Credit Suisse... Pure Storage (PSTG) initiated with a Perform at Oppenheimer... SeaWorld (SEAS) initiated with a Neutral at Janney Capital... Seattle Genetics (SGEN) initiated with an Overweight at Barclays... VCA Inc. (WOOF) initiated with an Outperform at Credit Suisse... Verizon (VZ) initiated with a Neutral at DA Davidson... Zoetis (ZTS) initiated with an Outperform at Credit Suisse.
08:05 EDTSGENSeattle Genetics to receive $20M milestone payment under ADCETRIS collaboration
Seattle Genetics (SGEN) announced that it will receive a one-time $20M milestone payment under its ADCETRIS collaboration with Takeda Pharmaceutical Company Limited (TKPYY). The milestone was triggered by Takeda surpassing annual ADCETRIS net sales of $200M in its territory during 2015. The milestone will be recognized as royalty revenue in the first quarter of 2016. In addition, the company announced that the European Commission recently approved a Type II variation that includes data on the retreatment of adult patients with relapsed or refractory Hodgkin lymphoma or R/R systemic anaplastic large cell lymphoma who previously responded to ADCETRIS and who later relapse. The label update follows a positive opinion from the Committee for Medicinal Products for Human Use in October 2015.
06:34 EDTZTSZoetis initiated with an Outperform at Credit Suisse
Credit Suisse analyst Erin Wilson initiated Zoetis with an Outperform rating and a $58 price target and named its a Top Pick in Animal Health. The analyst said Zoetis is highly leveraged to a rebound in industry fundamentals, and accelerating earnings growth from an improving cost and capital structure. Wilson is focused on underappreciated efficiency initiatives that should driver operating margin expansion over 900bps by 2017.
06:14 EDTTRIPTripAdvisor risk/reward now favorable into earnings, says Piper Jaffray
Piper Jaffray analyst Michael Olson says that following the significant underperformance of shares, the risk/reward for TripAdvisor (TRIP) is now favorable into the company's Q4 results. The slowdown in travel is already reflected into consensus estimates and concerns regarding the magnitude of the upcoming 2016 guide-down are overblown, Olson tells investors in a pre-earnings research note on the Online Content space. He reiterates an Overweight rating on the stock with a $120 price target. The analyst recommends avoiding Expedia (EXPE) and Priceline (PCLN) into the Q4 reports.
05:36 EDTSGENSeattle Genetics initiated with an Overweight at Barclays
Subscribe for More Information
February 3, 2016
08:02 EDTROLLRBC Bearings reports backlog of $351.3M at December 26
Subscribe for More Information
08:01 EDTROLLRBC Bearings reports Q3 EPS 73c, consensus 72c
Subscribe for More Information
07:07 EDTTCBKFIG Partners to hold a forum
Subscribe for More Information
February 2, 2016
11:50 EDTEXXIOptions with increasing put volume; BKLN AKS ROK MCHP EXXI TPX ALU TXT RCL
Subscribe for More Information
February 1, 2016
14:28 EDTSNNStryker deal for Smith & Nephew now unlikely, says Piper Jaffray
Subscribe for More Information
12:13 EDTSNNOn The Fly: Top stock stories at midday
Stocks on Wall Street were lower at midday, but off their worst levels of the day, as oil is once again being weighed on by worries of slower growth in China. Several M&A announcements helped fuel speculation that deal-making may be set to pick up, but the headwinds of lower oil prices and weak economic data are outweighing that potential boost and keeping stocks in the red to start the month. ECONOMIC EVENTS: In the U.S., personal income rose 0.3% in December, versus expectations for an increase of 0.2%, while spending was flat, versus expectations for an increase of 0.1%. Markit's manufacturing purchasing managers index for January dipped to 52.4 in the final January reading, down from the 52.7 flash reading and the below the 52.6 reading that was expected. The Institute for Supply Management's manufacturing index for January came in at 48.2, below the 48.4 that analysts expected. Construction spending rose 0.1% in December, which was weaker than the 0.6% increase that was forecast. In China, the statistics bureau's official manufacturing purchasing managers index fell to 49.4 in January from 49.7 in December. The private Caixin manufacturing PMI edged up to 48.4 from 48.2 in the prior reading, but both figures still remain in contraction territory. In Europe, Markit's manufacturing PMI for the euro zone dropped to 52.3 from December's 53.2, in-line with the earlier flash estimate. COMPANY NEWS: Shares of Twitter (TWTR) advanced 9% after tech reporter Jessica Lessin said private equity firm Silver Lake and investor Marc Andreessen have "considered some sort of deal" for the microblog service operator. Lessin noted in the report published on her site, The Information, that she did not know if deal talks are "active" now between Andreessen, Silver Lake and Twitter... Alere (ALR) surged 45% to $54 per share near midday after Abbott (ABT) agreed to acquire the company for $56 per share at a total expected equity value of $5.8B. In other Monday M&A news, Questar (STR) rose 22% after Dominion Resources (D) agreed to acquire it for $25 per share, or about $4.4B, and assume Questar's outstanding debt. Meanwhile, Stryker (SYK) announced a deal to acquire Sage Products for $2.775B in cash. The buyers' shares did not fare as well in the wake of the deal announcements, as Abbott slipped 0.5%, Dominion dipped 1% and Stryker fell 1%. Also lower were shares of Smith & Nephew (SNN), which slid fractionally as investors may have been concerned that Stryker's deal decreases the likelihood that it will come after S&N. Additionally, Smith & Nephew announced that its CEO Olivier Bohuon has been diagnosed with a "highly treatable" form of cancer. MAJOR MOVERS: Among the notable gainers was Lumber Liquidators (LL), which gained 8.5% after a judge accepted the company's $10M plea deal to settle timber source crime charges, according to media reports. Also higher was Chipotle (CMG), which rose 5.5% after The Wall Street Journal reported that the Centers for Disease Control and Prevention is expected to formally declare the end to its E.coli outbreak as soon as today. In addition, Sysco (SYY) and Aetna (AET) were up 7% and 2%, respectively, after reporting quarterly earnings. Among the noteworthy losers was Nokia (NOK), which fell 12% after it forecasted how much revenue it expects to gain from its IP portfolio after its patent deal with Samsung (SSNLF) and its shares were downgraded at Canaccord and BofA Merrill Lynch. Also lower was GoPro (GPRO), which was slid 5% after analysts from Piper Jaffray and Citi predicted that the company's guidance to be issued this week will disappoint investors. In addition, Roper Technologies (ROP) and ImmunoGen (IMGN) were down 6.5% and 5.7%, respectively, after reporting quarterly earnings. INDEXES: Near midday, the Dow was down 56.40, or 0.34%, to 16,409.90, the Nasdaq was down 12.25, or 0.27%, to 4,601.70, and the S&P 500 was down 6.51, or 0.34%, to 1,933.73.
08:26 EDTSNNSmith & Nephew reports CEO diagnosed with 'highly treatable' cancer
Smith & Nephew announced that Olivier Bohuon, Chief Executive Officer, has been diagnosed with a highly treatable form of cancer. "Olivier will remain Chief Executive Officer and be actively involved in running the Company through much of his treatment period, which will begin later this month. The treatment will include chemotherapy, and is expected to be completed by late autumn. The Board has approved provisional governance procedures to ensure the effective operation of Smith & Nephew during the treatment period, including Chairman Roberto Quarta providing executive oversight if required," the company stated.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use